Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Individualization of levodopa treatment using a microtablet dispenser and ambulatory accelerometry
University of Gothenburg, Sweden.
RISE - Research Institutes of Sweden, ICT, Acreo.
Karolinska Institutet, Sweden.
Uppsala University, Sweden.
Show others and affiliations
2018 (English)In: CNS Neuroscience & Therapeutics, ISSN 1755-5930, E-ISSN 1755-5949, Vol. 24, no 5, p. 439-447Article in journal (Refereed) Published
Abstract [en]

Aim: This 4-week open-label observational study describes the effect of introducing a microtablet dose dispenser and adjusting doses based on objective free-living motor symptom monitoring in individuals with Parkinson's disease (PD). Methods: Twenty-eight outpatients with PD on stable levodopa treatment with dose intervals of ≤4 hour had their daytime doses of levodopa replaced with levodopa/carbidopa microtablets, 5/1.25 mg (LC-5) delivered from a dose dispenser device with programmable reminders. After 2 weeks, doses were adjusted based on ambulatory accelerometry and clinical monitoring. Results: Twenty-four participants completed the study per protocol. The daily levodopa dose was increased by 15% (112 mg, P < 0.001) from period 1 to 2, and the dose interval was reduced by 12% (22 minutes, P = 0.003). The treatment adherence to LC-5 was high in both periods. The MDS-UPDRS parts II and III, disease-specific quality of life (PDQ-8), wearing-off symptoms (WOQ-19), and nonmotor symptoms (NMS Quest) improved after dose titration, but the generic quality-of-life measure EQ-5D-5L did not. Blinded expert evaluation of accelerometry results demonstrated improvement in 60% of subjects and worsening in 25%. Conclusions: The introduction of a levodopa microtablet dispenser and accelerometry aided dose adjustments improve PD symptoms and quality of life in the short term.

Place, publisher, year, edition, pages
2018. Vol. 24, no 5, p. 439-447
Keywords [en]
Accelerometry, Dose titration, Microtablets, Observational study, Parkinson's disease
National Category
Natural Sciences
Identifiers
URN: urn:nbn:se:ri:diva-33266DOI: 10.1111/cns.12807Scopus ID: 2-s2.0-85041030284OAI: oai:DiVA.org:ri-33266DiVA, id: diva2:1182098
Available from: 2018-02-12 Created: 2018-02-12 Last updated: 2019-07-02Bibliographically approved

Open Access in DiVA

fulltext(882 kB)1 downloads
File information
File name FULLTEXT01.pdfFile size 882 kBChecksum SHA-512
a518be6d65ca30bf9a7994bb4510bc97b4ca509b68ecc240ae6c3f77dc067ba4b36d692d6536d7e6842ed090284c980344e02ac0ab5bd4c30beb0acc7eb3c6b8
Type fulltextMimetype application/pdf

Other links

Publisher's full textScopus
By organisation
Acreo
In the same journal
CNS Neuroscience & Therapeutics
Natural Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 1 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 6 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
v. 2.35.7